Prenatal predictors of newborn intestinal obstruction
Official title: Neonatal Intestinal Obstruction: A Retrospective Observational Study on Prenatal Prognostic Factors and Postnatal Outcomes
Run by Meyer Children's Hospital IRCCS · NCT07434596 · Data updated 2026-11-12
This study will try to see if certain prenatal ultrasound signs—especially a specific amount of fetal bowel dilation—can predict which babies will have intestinal obstruction after birth.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Days to 28 Days |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Meyer Children's Hospital IRCCS Academic / other |
| Locations | 1 site (Florence, Florence) |
| Status | Recruiting |
| Started | March 11, 2025 |
| Main results expected | April 2026 |
| Study ends | December 2026 |
| Registry record updated | February 25, 2026 |
| Trial ID | NCT07434596 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Newborns from singleton pregnancies who had prenatal ultrasound suspicion of intestinal obstruction and complete postnatal follow-up at Meyer Children's Hospital are the intended group for this analysis.
✕Probably not a fit
Infants from multiple pregnancies, those without prenatal suspicion, or cases with missing prenatal or delivery data would not be represented and are unlikely to benefit from the study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This retrospective observational study reviews records of newborns at Meyer Children's Hospital who had prenatal ultrasound findings suggestive of intestinal obstruction and available postnatal follow-up. Investigators will compare prenatal ultrasound features—particularly measured fetal bowel dilation but also polyhydramnios, ascites, echogenic bowel, and other abdominal findings—with confirmed postnatal diagnoses of intestinal obstruction. The primary aim is to identify a specific cutoff value for fetal bowel dilation that best predicts true obstruction after birth. Inclusion requires singleton pregnancies with complete prenatal and postnatal data, while cases with missing delivery or ultrasound information are excluded.
Why it matters
Potential benefit: If successful, clinicians could more accurately predict which pregnancies will result in newborn intestinal obstruction, improving counseling and perinatal surgical planning.
How similar studies have gone: Previous studies have reported links between some prenatal ultrasound signs and neonatal intestinal obstruction, but findings have been mixed and a definitive bowel-dilation cutoff has not been universally established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Neonates from singleton pregnancies with prenatal ultrasound suspicion of intestinal obstructive pathology * Availability of complete postnatal follow-up data Exclusion Criteria: * Missing delivery data * Missing prenatal ultrasound data
Where it's running
-
Aou Meyer IRCSS
Florence, Florence, Italy Recruiting
Study contacts
- Study coordinator: Antonino Morabito
- Email: antonino.morabito@unifi.it
- Phone: 390555662545
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bowel Sounds and Day-to-Day Recovery After Colorectal Cancer Surgery
This study will test whether monitoring bowel sounds before and after colorectal cancer surgery can predict how quickly patients recover bowel function and resume eating.
-
Examining how different feeding methods affect gut health in newborns with gastrointestinal issues
This study is testing whether feeding newborns with gastrointestinal issues an exclusive human milk diet helps improve their gut health and feeding progress compared to standard feeding methods.
-
Autoimmune podocytopathy and anti-nephrin antibodies
This study tests whether children and adults with nephrotic syndrome have anti-nephrin autoantibodies and whether those antibodies relate to relapses and treatment response.
-
Pediatric leishmaniasis in Italy: clinical and treatment patterns
This project will collect medical information to see how leishmaniasis presents and is treated in children under 18 in Italy.
-
Infliximab level monitoring in children with inflammatory bowel disease
This project will test whether measuring infliximab levels in saliva and leftover blood during the first infusions helps monitor and personalize treatment for children and teens (ages 3–18) with Crohn's disease or ulcerative colitis.
-
Camptodactyly–Arthropathy–Coxa Vara–Pericarditis (CACP) syndrome patient registry and genetic review
This registry collects clinical and genetic information to better understand CACP syndrome in children with confirmed PRG4 mutations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.